Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

7.3K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.3K
Blinding01:11

Blinding

2.6K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.6K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

422
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
422
Crossover Experiments01:16

Crossover Experiments

3.0K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
3.0K
Group Design02:01

Group Design

9.7K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
9.7K
Experimental Designs01:16

Experimental Designs

13.8K
An experimental design is a systematic process that allows researchers to evaluate the relationship between dependent and independent variables. There are three widely used types of experimental design - pre-experimental design, true experimental design, and quasi-experimental design. In pre-experimental design, the researcher compares the data before and after some interventions or treatments. The true-experimental design has more than one purposefully created group, a commonly measured...
13.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sample Size Determination for Decision-centered Pragmatic Trials.

Journal of clinical epidemiology·2026
Same author

Effects of polygenic risk score communication on short term health outcomes: systematic review and meta-analysis.

BMJ medicine·2026
Same author

Reclassification and weighting of multiple causes of death: US death certificates 2003-2023.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Reporting of Cohort and Routinely Collected Data in Randomised Controlled Trial Protocols (SPIRIT-ROUTINE): extension checklist with explanation and elaboration.

BMJ (Clinical research ed.)·2026
Same author

Characteristics, reporting, risk of bias and pragmatism in prehospital emergency care randomised trials from 2010 to 2024: a protocol for a meta-epidemiological study.

BMJ open·2026
Same author

Highlighting Rigor, Reproducibility, and Transparency of Research in an Academic CV.

Clinical and translational science·2026
Same journal

Correction to I.M. Matters News: Sleep medicine for seniors.

Annals of internal medicine·2026
Same journal

Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

Annals of internal medicine·2026
Same journal

Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

Annals of internal medicine·2026
Same journal

Grappling with GLP-1 prescribing.

Annals of internal medicine·2026
See all related articles

Related Experiment Video

Updated: Sep 15, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K

Single-Arm Trials Can Provide Randomized Real-World Evidence: The Random Invitation Single-Arm Trial Design.

Perrine Janiaud1, John P A Ioannidis2, Benjamin Kasenda3

  • 1Pragmatic Evidence Lab, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, and Department of Clinical Research, University of Bern, Bern, Switzerland (P.J.).

Annals of Internal Medicine
|July 14, 2025
PubMed
Summary
This summary is machine-generated.

A new random invitation single-arm trial (RISAT) design improves generalizability and comparative evidence quality. This approach enhances participation fairness and real-world evidence validity for better healthcare decisions and drug approvals.

More Related Videos

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.7K
Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

2.4K

Related Experiment Videos

Last Updated: Sep 15, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.7K
Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

2.4K

Area of Science:

  • Clinical Trials Methodology
  • Real-World Evidence Generation
  • Health Care Decision Making

Background:

  • Single-arm trials (SATs) are valuable for exploring treatment feasibility and effects but suffer from limited generalizability and poor comparative evidence quality.
  • Traditional SATs often use convenience sampling, restricting participant pools and potentially biasing results.
  • The limitations of SATs hinder their utility for robust healthcare decision-making.

Purpose of the Study:

  • To introduce a novel single-arm trial design, the random invitation single-arm trial (RISAT), aimed at enhancing generalizability and comparative evidence quality.
  • To present a method for generating higher-value evidence from early-phase trials, supporting accelerated drug approval processes.
  • To improve the fairness of research participation and the applicability of trial findings to broader patient populations.

Main Methods:

  • The RISAT design incorporates a data infrastructure for routinely collected real-world data (RWD) with participant consent.
  • A subset of participants within the RWD infrastructure is randomly invited to the RISAT, with non-invitees not contacted.
  • Invitees are offered the intervention, and all invitees are followed prospectively, regardless of acceptance; optional randomized comparisons can utilize RWD infrastructure.

Main Results:

  • RISATs offer fairer access to research participation compared to traditional single-arm trials.
  • The design improves the applicability and generalizability of trial results.
  • RISATs provide a form of randomized real-world evidence, increasing the value and validity of generated data.

Conclusions:

  • The random invitation single-arm trial (RISAT) design offers significant advantages over traditional single-arm trials in terms of generalizability and evidence quality.
  • At minimal additional cost, RISATs can generate higher-value evidence, supporting accelerated drug approvals and informed healthcare decisions.
  • This innovative approach leverages existing real-world data infrastructure to produce more credible and valid research findings.